STOCK Act, US House only, disclosed up to 45 days after the trade
Funds added, last quarter
384
13F, latest reported quarter
Conversions, 180 days
1
Codes C/M, not in net · $250.9K priced
What the filings say about LDOS
Insiders, 180 days
-$1.7M net sold
2 sellers · 0% of sales under a 10b5-1 plan
Congress, 1 year
No trades
Last one: sale, 2025-05-13
Planned sales (Form 144), 90 days
$1.5M
2 notices
Leidos insider trades (Form 4)
Form 4 buys and sells (codes P and S). Grants, option exercises
and conversions excluded.
Over the last 180 days, Leidos Holdings, Inc. insiders sold a net $1.7M of stock across 68 Form 4 purchases and sales, with no insider buying. Source: SEC Form 4 filings, as of 2026-10-27.
9 earlier Form 4 trades (code P or S) here by this insider (9 sales), the last on May 7, 2026.
The trade is 9.8% of the 10,204 shares held after it.
1 other insider sold within 30 days.
384 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director May Gary Stephen sold about $140.8K of LDOS on Sep 1, 2026; 1 other insider sold within 30 days and 384 funds added in the latest 13F quarter.
2 earlier Form 4 trades (code P or S) here by this insider (1 buy, 1 sale), the last on Nov 20, 2024.
The trade is 23.8% of the 35,773 shares held after it.
1 other insider sold within 30 days.
384 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director Geer Noel B sold about $1.2M of LDOS on Aug 11, 2026; 1 other insider sold within 30 days and 384 funds added in the latest 13F quarter.
2 earlier Form 4 trades (code P or S) here by this insider (1 buy, 1 sale), the last on Nov 20, 2024.
The trade is 4.4% of the 34,273 shares held after it.
1 other insider sold within 30 days.
384 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director Geer Noel B sold about $211.6K of LDOS on Aug 11, 2026; 1 other insider sold within 30 days and 384 funds added in the latest 13F quarter.
8 earlier Form 4 trades (code P or S) here by this insider (8 sales), the last on Aug 11, 2025.
The trade is 14.6% of the 10,137 shares held after it.
1 other insider sold within 30 days.
384 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director May Gary Stephen sold about $197.0K of LDOS on May 7, 2026; 1 other insider sold within 30 days and 384 funds added in the latest 13F quarter.
3 earlier Form 4 trades (code P or S) here by this insider (3 sales), the last on Jan 20, 2026.
The trade is 3.9% of the 49,561 shares held after it.
1 other insider sold within 30 days.
384 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Sector President Porter Elizabeth A sold about $304.0K of LDOS on Apr 7, 2026; 1 other insider sold within 30 days and 384 funds added in the latest 13F quarter.
68 transactions on record
Since filing: total return from the first close after the filing to the latest close, dividend-adjusted. Not a forecast.
Context lines are counts over the filings above and returns from our own price history, never a price level. Not investment advice.
Nobody has filed for crossing 5%. That is a fact, not missing data.
LDOS planned insider sales (Form 144)
Notice of intent to sell, filed before any sale
May Gary Stephen
Filed 2026-09-01
$140.8K
Noel B. Geer
Filed 2026-08-11
$1.4M
LDOS mutual fund holders (N-PORT)
Funds ranked by the share of their own portfolio in this stock (N-PORT).
Aztlan North America Nearshoring Stock Selection ETF
$1.0M position · as of 2026-07-31
3.4%
Monarch Dividend Plus Index ETF
$2.0M position · as of 2026-05-31
3.3%
Global X Defense Tech ETF
$221.5M position · as of 2026-05-31
2.8%
Frank Value Fund
$947.3K position · as of 2026-06-30
2.7%
Alpha Architect U.S. Quantitative Value ETF
$10.9M position · as of 2026-06-30
2.0%
Bushido Capital US Equity ETF
$12.9M position · as of 2026-07-31
2.0%
SEC N-PORT, monthly, about 60 days late · funds ≥ $10M ·
% is the share of the fund's own portfolio
Government contracts
Award ceilings over the contract's life, subsidiaries included.
Not annual revenue (USASpending.gov).
Department Of Health And Human Services
TAS::75 0849::TAS OPER OF GOVT R&D GOCO FACILITIES · 2008-09-26
$4.8B
National Science Foundation
SCIENCE OPERATION AND MAINTENANCE SUPPORT FOR THE UNITED STATES ANTARCTIC PROGRAM · 2011-12-23
$3.3B
Department Of Health And Human Services
NCI OPERATIONAL TASK ORDER · 2020-08-31
$1.8B
Social Security Administration
ITSSC TASK ORDER FOR SYSTEMS · 2022-06-30
$1.3B
General Services Administration
MILITARY AND FAMILY LIFE COUNSELING. REQUIREMENT FOR WORLDWIDE NON MEDICAL CONFIDENTIAL COUNSELING S · 2021-02-01
$1.2B
Department Of Energy
RESEARCH SUPPORT SERVICES (RSS) · 2018-12-31
$1.1B
Federal awards ≥ $25M in the last 90 days, matched via the SAM.gov parent registry
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
Insiders have filed to sell, before selling.
The record shows a net $1.7M sold by insiders over 180 days, 384 funds added last quarter, $1.5M in planned Form 144 sales. Each figure is a federal filing, dated the day it went public.
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
$17.6B
four quarters, 2025-07-05 to 2026-07-03
Revenue, TTM LDOS
FY Jan 2026
$17.2B
FY Jan 2025
$16.7B
FY Dec 2023
$15.4B
FY Dec 2022
$14.4B
FY Dec 2021
$13.7B
Jul 2026
$4.6B
Apr 2026
$4.4B
Jan 2026
$4.2B
Oct 2025
$4.5B
Jul 2025
$4.3B
Apr 2025
$4.2B
Jan 2025
$4.4B
Sep 2024
$4.2B
At each fiscal year end
Single quarter
Net margin, TTM
+7.8%
net income over revenue, 2025-07-05 to 2026-07-03
Net margin, TTM LDOS
FY Jan 2026
+8.4%
FY Jan 2025
+7.5%
FY Dec 2023
+1.3%
FY Dec 2022
+4.8%
FY Dec 2021
+5.5%
Jul 2026
+7.8%
Apr 2026
+7.5%
Jan 2026
+7.8%
Oct 2025
+8.2%
Jul 2025
+9.2%
Apr 2025
+8.6%
Jan 2025
+6.5%
Sep 2024
+8.7%
At each fiscal year end
Single quarter
Free cash flow, TTM
$2.2B
operating cash flow minus capex, 2025-07-05 to 2026-07-03
Free cash flow, TTM LDOS
FY Jan 2026
$1.6B
FY Jan 2025
$1.3B
FY Dec 2023
$980.0M
FY Dec 2022
$863.0M
FY Dec 2021
$929.0M
Jul 2026
$761.0M
Apr 2026
$270.0M
Jan 2026
$452.0M
Oct 2025
$680.0M
Jul 2025
$457.0M
Apr 2025
$36.0M
Jan 2025
$208.0M
Sep 2024
$624.0M
At each fiscal year end
Single quarter
Debt to equity
1.14x
long-term 2026-07-03 plus current 2026-07-03; equity 2026-07-03
Debt to equity LDOS
FY Jan 2026
0.95x
FY Jan 2025
1.06x
FY Dec 2023
1.11x
FY Dec 2022
1.14x
FY Dec 2021
1.18x
Jul 2026
1.14x
Apr 2026
1.26x
Jan 2026
0.95x
Oct 2025
0.95x
Jul 2025
1.09x
Apr 2025
1.21x
Jan 2025
1.06x
Sep 2024
1.01x
At each fiscal year end
Trailing four quarters at each quarter end
Cash flow to debt
0.38x
TTM operating cash flow over long-term 2026-07-03 plus current 2026-07-03
Cash flow to debt LDOS
FY Jan 2026
0.38x
FY Jan 2025
0.31x
FY Dec 2023
0.25x
FY Dec 2022
0.20x
FY Dec 2021
0.20x
Jul 2026
0.38x
Apr 2026
0.31x
Jan 2026
0.38x
Oct 2025
0.33x
Jul 2025
0.29x
Apr 2025
0.27x
Jan 2025
0.31x
Sep 2024
0.31x
At each fiscal year end
Trailing four quarters at each quarter end
Return on equity
+27.7%
TTM net income over average of 2025-07-04 and 2026-07-03
Return on equity LDOS
FY Jan 2026
+31.0%
FY Jan 2025
+29.1%
FY Dec 2023
+4.7%
FY Dec 2022
+15.9%
FY Dec 2021
+18.5%
Jul 2026
+27.7%
Apr 2026
+30.5%
Jan 2026
+31.0%
Oct 2025
+29.5%
Jul 2025
+30.8%
Apr 2025
+31.3%
Jan 2025
+29.1%
Sep 2024
+27.4%
At each fiscal year end
Trailing four quarters at each quarter end
Return on assets
+9.4%
TTM net income over average of 2025-07-04 and 2026-07-03
Return on assets LDOS
FY Jan 2026
+10.9%
FY Jan 2025
+9.8%
FY Dec 2023
+1.5%
FY Dec 2022
+5.2%
FY Dec 2021
+5.8%
Jul 2026
+9.4%
Apr 2026
+9.9%
Jan 2026
+10.9%
Oct 2025
+10.5%
Jul 2025
+10.6%
Apr 2025
+10.2%
Jan 2025
+9.8%
Sep 2024
+9.2%
At each fiscal year end
Trailing four quarters at each quarter end
Return on invested capital
+15.5%
operating income after a 22.2% effective tax rate, over long-term 2026-07-03 plus current 2026-07-03 plus average of 2025-07-04 and 2026-07-03 minus cash
Return on invested capital LDOS
FY Jan 2026
+19.4%
FY Jan 2025
+16.9%
FY Dec 2023
+3.8%
FY Dec 2022
+9.9%
FY Dec 2021
+10.6%
Jul 2026
+15.5%
Apr 2026
+15.6%
Jan 2026
+19.4%
Oct 2025
+18.7%
Jul 2025
+17.6%
Apr 2025
+17.0%
Jan 2025
+16.9%
Sep 2024
+16.6%
At each fiscal year end
Trailing four quarters at each quarter end
Return on capital employed
+17.6%
operating income (EBIT proxy) over average of 2025-07-04 and 2026-07-03 minus current liabilities
Return on capital employed LDOS
FY Jan 2026
+21.0%
FY Jan 2025
+19.1%
FY Dec 2023
+6.6%
FY Dec 2022
+11.4%
FY Dec 2021
+11.7%
Jul 2026
+17.6%
Apr 2026
+18.6%
Jan 2026
+21.0%
Oct 2025
+20.5%
Jul 2025
+20.4%
Apr 2025
+19.5%
Jan 2025
+19.1%
Sep 2024
+18.3%
At each fiscal year end
Trailing four quarters at each quarter end
P/E, trailing
12.71x
close 2026-10-23 over four quarters of diluted EPS, 2025-07-05 to 2026-07-03
P/E, trailing LDOS
FY Jan 2026
16.50x
FY Jan 2025
15.98x
FY Dec 2023
76.23x
FY Dec 2022
21.29x
FY Dec 2021
16.93x
Jul 2026
10.16x
Apr 2026
14.56x
Jan 2026
16.50x
Oct 2025
18.30x
Jul 2025
15.60x
Apr 2025
13.43x
Jan 2025
15.98x
Sep 2024
18.19x
At each fiscal year end
Trailing four quarters at each quarter end
Enterprise value
$22.4B
market value at close 2026-10-23 on 2026-07-28 shares, plus long-term 2026-07-03 plus current 2026-07-03, minus cash 2026-07-03
Enterprise value LDOS
FY Jan 2026
$27.0B
FY Jan 2025
$23.5B
FY Dec 2023
$18.9B
FY Dec 2022
$18.8B
FY Dec 2021
$16.8B
Jul 2026
$19.0B
Apr 2026
$26.0B
Jan 2026
$27.0B
Oct 2025
$28.8B
Jul 2025
$25.4B
Apr 2025
$21.8B
Jan 2025
$23.5B
Sep 2024
$25.1B
At each fiscal year end
Trailing four quarters at each quarter end
FCF yield
+12.7%
TTM free cash flow over market value at close 2026-10-23
FCF yield LDOS
FY Jan 2026
+6.9%
FY Jan 2025
+6.5%
FY Dec 2023
+6.6%
FY Dec 2022
+6.0%
FY Dec 2021
+7.4%
Jul 2026
+15.8%
Apr 2026
+9.3%
Jan 2026
+6.9%
Oct 2025
+5.5%
Jul 2025
+6.3%
Apr 2025
+7.0%
Jan 2025
+6.5%
Sep 2024
+6.2%
At each fiscal year end
Trailing four quarters at each quarter end
PEG, trailing
8.38x
P/E over trailing EPS growth of 2%: four quarters to 2026-07-03 against the four to 2025-07-04
PEG, trailing LDOS
FY Jan 2026
0.80x
FY Jan 2025
0.03x
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
0.83x
Jul 2026
6.70x
Apr 2026
1.44x
Jan 2026
0.80x
Oct 2025
0.84x
Jul 2025
0.07x
Apr 2025
0.04x
Jan 2025
0.03x
Sep 2024
0.02x
At each fiscal year end
Trailing four quarters at each quarter end
Price as of 2026-10-23. Hover or tap a tile for its yearly and quarterly history.Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
LDOS ranks highest on institutional and government (91st percentile) and profitability (76th), and lowest on insider conviction (24th), among Software & IT peers.
Profitability
76
Inputs
Return on equity+27.7% · 83 pct, sector of 286
Return on assets+9.4% · 80 pct, sector of 381
Return on invested capital+15.5% · 55 pct, sector of 78
Return on capital employed+17.6% · 86 pct, sector of 294
Financial health
39
Inputs
Debt to equity1.14x · 16 pct, sector of 288
Cash flow to debt0.38x · 62 pct, sector of 241
Growth
56
Inputs
Revenue growth, YoY+3.2% · 38 pct, sector of 480
Backlog growth, YoY+25.0% · 73 pct, sector of 182
Insider conviction
24
Inputs
Net Form 4 buying (codes P and S), 180d-$1.7M · 48 pct, sector of 285
Insider buyers, 180d0 · 0 pct, sector of 290
Institutional and government
91
Inputs
Funds adding, latest quarter384 · 89 pct, sector of 415
Congress net buyers, 365dno Congress trades in 365 days
Federal contracts, 180d$351.1M · 90 pct, universe of 69
Lobbying spend, 4 quarters$7.4M · 95 pct, sector of 85
Risk and compliance
49
Inputs
Short interest, % of float+3.8% · 58 pct, sector of 530
Recalls per $1B revenue, 3ynot measured for this sector, almost no peer has an event
EPA cases per $1B revenue, 5ynot measured for this sector, almost no peer has an event
New text in Risk Factors, latest 10-K+13.1% · 39 pct, sector of 316
1 not measured: US patents
US patents needs 1 of 2 inputs, 0 present: patent data not loaded yet
6 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored
LDOS filings, in plain words
Are Leidos insiders buying or selling LDOS?
In the 180 days to 2026-10-27, Leidos insiders were net sellers, a net $1.7M across purchases and sales reported on Form 4, by 2 sellers.
Have members of Congress traded LDOS?
Yes, but not in the year to 2026-10-27; the latest on record is a sale by Gerald E. Connolly dated 2025-05-13.
Are there planned insider sales of LDOS?
Yes. 2 Form 144 notices of planned insider sales were filed in the 90 days to 2026-10-27, covering $1.5M of stock; the latest, by May Gary Stephen, was filed 2026-09-01.
Read the full summary
In the 180 days to 2026-10-27, Leidos insiders were net sellers of LDOS, a net $1.7M across purchases and sales reported on Form 4 by 2 sellers. None of the 4 insider sales was flagged as made under a Rule 10b5-1 plan. Members of Congress have disclosed trades in LDOS, none in the last year; the latest on record is a sale by Gerald E. Connolly dated 2025-05-13. Insiders filed 2 Form 144 notices of intent to sell in the 90 days to 2026-10-27, covering $1.5M of stock. Each figure is counted from SEC and House filings as of 2026-10-27, dated the day the filing was made public.
Explore insider trading and ownership data
Every company we track, ranked by each kind of filing
No password to create and no card required. We store your email address, your watchlist and your preferences, nothing else.
PRIVACY & COOKIES
We track filings, not you.
Essential cookies keep you signed in and remember this choice.
Google Analytics 4 and Microsoft Clarity load only if you allow them here; they
count visits and record how pages are used. We run no advertising and never sell
data. Details in the privacy policy. Change this any time
via "Cookie settings" in the footer.